Medication Guide App

Label Changes for:

Geodon (ziprasidone) Capsules, Injection and Oral Suspension

July 2013

Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

July 2013

WARNINGS AND PRECAUTIONS

Metabolic Changes
  • Atypical antipsychotic drugs have been associated with metabolic changes that may increase cardiovascular/cerebrovascular risk. These metabolic changes include hyperglycemia, dyslipidemia, and body weight gain. While all of the drugs in the class have been shown to produce some metabolic changes, each drug has its own specific risk profile.
     

 

March 2013

WARNINGS AND PRECAUTIONS

Hyperprolactinemia
  • ...Long-standing hyperprolactinemia when associated with hypogonadism may lead to decreased bone density.

 

Hide
(web1)